| Rebekah Anne Kennedy, | |
|
17706 Interstate 30 N Ste 3, Benton, AR 72019-2930 | |
| (501) 315-4414 | |
| Not Available |
| Full Name | Rebekah Anne Kennedy |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 17706 Interstate 30 N Ste 3, Benton, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043823008 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 201218 (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Rebekah Anne Kennedy, 17706 Interstate 30 N Ste 3, Benton, AR 72019-2930 Ph: () - | Rebekah Anne Kennedy, 17706 Interstate 30 N Ste 3, Benton, AR 72019-2930 Ph: (501) 315-4414 |
News Archive
BioScrip, Inc. today announced it has signed a definitive agreement to acquire Critical Homecare Solutions ("CHS"), a leading provider of home infusion and home health agency services to patients suffering from chronic and acute medical conditions.
People with complete color blindness are born unable to distinguish colors. They see less sharply and are highly sensitivity to glare.
The majority of women who chose nitrous oxide (laughing gas) to manage labor pain, ultimately decide to have an epidural, according to new research presented at the ANESTHESIOLOGY 2016 annual meeting.
Medicago Inc. (TSX: MDG; OTCQX: MDCGF), a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced the successful production of a Rotavirus VLP vaccine candidate comprising all four structural antigens of rotavirus (VP2, VP4, VP6 and VP7) using Medicago's plant-based manufacturing platform.
Amgen and Millennium: The Takeda Oncology Company, a subsidiary of Takeda Pharmaceutical Company Limited , today announced that enrollment in the Phase 3 MONET1 trial evaluating motesanib (AMG 706) in combination with paclitaxel and carboplatin for the first-line treatment of advanced non-small cell lung cancer (NSCLC) has been temporarily suspended following a planned safety data review of 600 patients by the study's independent Data Monitoring Committee (DMC). Motesanib is part of a broad co-development program between Amgen and Takeda.
› Verified 1 days ago
Arkansas Therapy Outreach, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3851 Legacy Village Dr, Benton, AR 72015 Phone: 501-350-7572 Fax: 501-776-4059 | |
Cassandra Powell, M.S.CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Park Dr, Benton, AR 72015 Phone: 501-315-0136 | |
Taylor Gibbs Crosby, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 17706 Interstate 30 N Ste 3, Benton, AR 72019 Phone: 501-315-4414 | |
Ryan Russell, MSSLP.CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6701 Highway 67, Benton, AR 72015 Phone: 501-860-0777 | |
Jessica Faye Huffty, MS, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3214 Winchester, Benton, AR 72015 Phone: 501-315-4414 Fax: 501-315-3467 | |
Mckenna Lynn Zeringue, M.S. CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 17706 I 30, Benton, AR 72019 Phone: 501-315-4414 |